Atlas Trials

Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder

Clinical trial NCT03514784 · COMPLETED

Trial details

NCT number
NCT03514784
Sponsor
The University of Texas Health Science Center, Houston
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Autism Spectrum DisorderGastrointestinal Symptoms
Start date
2016-05-01
Primary completion
2025-07-30
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.